Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis.

Trial Profile

Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Dermatomyositis; Polymyositis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 26 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 05 Aug 2016 Planned End Date changed from 1 May 2016 to 1 Sep 2016.
    • 08 Jan 2016 Planned End Date changed from 1 Jul 2016 to 1 May 2016 as reported by ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top